Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Tremor in neuropathies of different origin.
Parent-of-Origin Effects Implicate Epigenetic Regulation of Experimental Autoimmune Encephalomyelitis and Identify Imprinted Dlk1 as a Novel Risk Gene.
Influence of drugs on gap junctions in glioma cell lines and primary astrocytes in vitro.
Laser speckle imaging to improve clinical outcomes for patients with trigeminal neuralgia undergoing radiofrequency thermocoagulation.
Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis.
Genetically Modified Pig Models for Neurodegenerative Disorders.
How scientists fool themselves - and how they can stop.
The Impact of Increasing Multiple Sclerosis (Ms) Severity Level on Employment and Caregiver Burden.
The Scandinavian paradox revisited: Editorial comment on Berg-Hansen et al. 'High prevalence and no latitude gradient of multiple sclerosis in Norway'.
Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use.
Spinal cord ring enhancement in patients with neuromyelitis optica.
Antibodies to myelin oligodendrocyte glycoprotein are uncommon in Japanese opticospinal multiple sclerosis.
Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy.
Multiple sclerosis: Biomarkers predict conversion from clinically isolated syndrome to multiple sclerosis.
Generalised cognitive motor interference in multiple sclerosis.
High variability of fabry disease manifestations in an extended italian family.
Platelets and vascular inflammation of the brain.
Multiple Sclerosis-related Uveitis: Does MS Treatment Affect Uveitis Course?
Oxidative stress and antioxidants in neurological diseases: is there still hope?
Inherited and acquired disorders of myelin: The underlying myelin pathology.
Is the Iranian Revolution to Blame for the Increasing Incidence of Multiple Sclerosis in Iran?.
Serum uric acid levels and their correlation with clinical and cerebrospinal fluid parameters in patients with neuromyelitis optica.
Validation of the automated method VIENA: An accurate, precise, and robust measure of ventricular enlargement.
Indices of Cognitive Dysfunction in Relapsing-Remitting Multiple Sclerosis: Intra-individual Variability, Processing Speed, and Attention Network Efficiency.
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects.
Pages
« first
‹ previous
…
537
538
539
540
541
542
543
544
545
…
next ›
last »